Cardio Diagnostics Holdings Inc. Common stock (CDIO)
Stock · NASDAQ · Health Care
$1.84as of 8/28/2026
Price chart
Open in TradingViewActive signals
About CDIO
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable C…
- Sector
- Health Care
- Industry
- Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Employees
- 15
- Website
- www.cardiodiagnosticsinc.com
Fundamentals
- 1-day range
- $1.86$2.04
- Market cap
- $4.91M
- P/E (trailing)
- —
- P/E (forward)
- -8.12
- EPS (trailing)
- $-3.38
- Dividend yield
- —
- Beta
- 2.29
- Avg. volume
- 67.7K
How Cardio Diagnostics Holdings Inc. Common stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 13, 2026 · via SEC EDGAR / Finnhub
Cardio Diagnostics Holdings Inc. Common stock Competitors
Chosen by industry and closest market cap.
- CDIOCardio Diagnostics Holdings Inc. Common stock$1.84▼ 1.60%Market cap $4.91MP/E —$0.97$7.91
- BMRABiomerica Inc. Common Stock$2.14▲ 1.67%Market cap $4.94MP/E —$1.45$3.31
- QCLSQ/C Technologies Inc. Common Stock$2.37▲ 0.00%Market cap $21.99MP/E —$2.3$8.94
- IMDXInsight Molecular Diagnostics Inc. Common Stock$4.16▼ 3.03%Market cap $154.99MP/E —$2.33$8.51
- TKNOAlpha Teknova Inc. Common Stock$7.13▼ 2.46%Market cap $350.10MP/E —$1.91$7.84
- ACHVAchieve Life Sciences Inc. Common Shares$8.09▼ 1.16%Market cap $672.42MP/E —$2.62$8.61
- NTLAIntellia Therapeutics Inc. Common Stock$12.87▼ 1.83%Market cap $1.57BP/E —$7.95$28.25
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| CDIO Cardio Diagnostics Holdings Inc. Common stock | $4.91M | — | $1.84 | ▼ 1.60% | $0.97$7.91 |
| BMRA Biomerica Inc. Common Stock | $4.94M | — | $2.14 | ▲ 1.67% | $1.45$3.31 |
| QCLS Q/C Technologies Inc. Common Stock | $21.99M | — | $2.37 | ▲ 0.00% | $2.3$8.94 |
| IMDX Insight Molecular Diagnostics Inc. Common Stock | $154.99M | — | $4.16 | ▼ 3.03% | $2.33$8.51 |
| TKNO Alpha Teknova Inc. Common Stock | $350.10M | — | $7.13 | ▼ 2.46% | $1.91$7.84 |
| ACHV Achieve Life Sciences Inc. Common Shares | $672.42M | — | $8.09 | ▼ 1.16% | $2.62$8.61 |
| NTLA Intellia Therapeutics Inc. Common Stock | $1.57B | — | $12.87 | ▼ 1.83% | $7.95$28.25 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
Insider Activity
Insider Actions →- Fung Peter K · June 30, 2026 · Grant2.9K @ $2.19
- Betts Wendy J · June 30, 2026 · Grant2.9K @ $2.19
- Paul Frederick Burton · June 30, 2026 · Grant2.9K @ $2.19
- James Intrater · June 30, 2026 · Grant2.9K @ $2.19
- Fung Peter K · March 31, 2026 · Grant3.2K @ $1.95
- Betts Wendy J · March 31, 2026 · Grant3.2K @ $1.95
- Paul Frederick Burton · March 31, 2026 · Grant3.2K @ $1.95
- James Intrater · March 31, 2026 · Grant3.2K @ $1.95
Institutional Ownership
March 31, 2026
- Total shares held
- 272.4K
- Total value held
- $409.4K
- Institutional holders
- 15
- Unknown81.3K
- Unknown62.5K
- Unknown34.7K
- Unknown32.2K
- Unknown20.2K
- Unknown15.3K
- Unknown13.9K
- Unknown9.9K
- Unknown2.2K
- Unknown104
See the full, filterable feed with live charts on the MarketWall dashboard.